TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
NACIA Biotechnology AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2021/12 | 2020/12 |
| Turnover |
0
|
0
|
222 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-149
|
-14
|
-30 |
| EBITDA |
-149
|
-16
|
-31 |
| Total assets |
1,679
|
1,840
|
1,877 |
| Current assets |
1,679
|
1,840
|
1,877 |
| Current liabilities |
1,881
|
1,850
|
1,868 |
| Equity capital |
-203
|
-4
|
10 |
| - share capital |
67
|
73
|
74 |
| Employees (average) |
2
|
2
|
0 |
Financial ratios
| Fiscal year | 2023/12 | 2021/12 | 2020/12 |
| Solvency |
-12.1%
|
-0.2%
|
0.5% |
| Turnover per employee |
0
|
0 | |
| Profit as a percentage of turnover | -13.5% | ||
| Return on assets (ROA) |
-8.9%
|
-0.8%
|
-1.6% |
| Current ratio |
89.3%
|
99.5%
|
100.5% |
| Return on equity (ROE) |
73.4%
|
350.0%
|
-300% |
| Change turnover |
0
|
-217
|
222 |
| Change turnover % | -100% | ||
| Chg. No. of employees |
0
|
2
|
-2 |
| Chg. No. of employees % | 0% | -100% |
Total value of public sale
| Fiscal year | 2023/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.